skip to search skip to navigation skip to main content

Archive: November 2015

Betmiga launched in Lebanon

13th November 2015 in Product Launches

Beirut, Lebanon; November 13, 2015: Astellas Pharma Middle East, North and Sub-Saharan Africa (MENA/SSA), today announced that its latest innovative treatment for overactive bladder (OAB) is now available in Lebanon. The oral medication contains the active ingredient mirabegron, and provides a new treatment option for OAB patients. Overactive bladder (OAB) is the name of a…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2019 Astellas Pharma